Evidence shows that clients treated by clinicians who undergo ten-day intensive training experience significantly greater reductions in suicide attempts and self-harm behaviors. This finding, derived from a comprehensive systematic review by Melanie Harris, Carolien Lamers, and Michaela Swales,
Industry leaders must transition from a strategy of achieving statistical significance against outdated standards of care to one of satisfying the structural requirements for attributable efficacy. The oncology drug development sector is currently navigating a structural crisis widely referred to
Following a $2.2 billion acquisition of Forte Biosciences, this latest deal underscores argenx’s aggressive strategy for diversifying its immunology portfolio. The Dutch-Belgian biotechnology powerhouse has finalized an agreement to acquire Unnatural Products Inc., a California-based firm s
Mississippi County currently relies on only eight full-time family medicine physicians to serve an entire region that is experiencing rapid industrial growth and expansion. This critical shortage has prompted a landmark philanthropic investment aimed at fortifying the medical landscape of the
Molecular and clonal biomarkers will be integrated into upcoming clinical trials to measure whether the therapy is successfully reducing the population of abnormal stem cells. This clinical strategy underscores the mission of Alethio Therapeutics, which recently closed a pivotal $90 million Series
Clinical data for Revolution Medicines’ new oral pancreatic cancer drug suggests the treatment can more than double the overall survival period for terminal patients. This breakthrough arrives at a pivotal moment, as the broader healthcare sector transitions from a multi-year period of relative s
